Showing results (1141-1150 of 1,174) with videos related to
Sort By:
Pageof 118
Aperture Neuro|February 12, 2026
BrainEffeX: A Web App for Exploring fMRI Effect SizesHallee Shearer, Matt Rosenblatt, Jean Ye, et al.Current Eye Research|March 17, 2021
Manhattan Vision Screening and Follow-Up Study in Vulnerable Populations: 1-Month Feasibility ResultsLisa A Hark, Camille S Tan, Yocheved S Kresch, et al.Journal of Glaucoma|January 25, 2021
Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and MethodologyLisa A Hark, Yocheved S Kresch, Carlos Gustavo De Moraes, et al.Biorxiv : the Preprint Server for Biology|July 1, 2024
Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machineryKeith A Berggren, Saloni Sinha, Aaron E Lin, et al.Development (Cambridge, England)|October 9, 2014
ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesisParaskevi Goggolidou, Jonathan L Stevens, Francesco Agueci, et al.Journal of Hematology & Oncology|January 6, 2026
Multiple myeloma risk linked to DNA damage response genesMichael Conry, Irina Ostrovnaya, Yelena Kemel, et al.American Journal of Ophthalmology|January 23, 2023
Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized TrialLisa A Hark, Jason D Horowitz, Prakash Gorroochurn, et al.Journal of Patient-Reported Outcomes|October 9, 2023
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trialChristel McMullan, Ameeta Retzer, Sarah E Hughes, et al.Neurology. Genetics|August 15, 2022
A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline ResultsStella Jensen-Roberts, Taylor L Myers, Peggy Auinger, et al.Pageof 118